| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 05/07/2008 | CN101175735A Stabilized compositions of volatile alkylating agents and methods of using thereof |
| 05/07/2008 | CN100386313C Novel herbicides |
| 05/06/2008 | US7368568 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use |
| 05/06/2008 | US7368567 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists |
| 05/06/2008 | US7368415 Substituted beta-(oxazolidin-3-ylcarbonyl)styrenes: 1-[2-(2,4-Dimethyl-cyclohex-3-enyl)-oxazolidin-3-yl]-3-(2-hydroxy-phenyl)-propenone; for delivering fragrances to a laundary detergent, shampoo or hair conditioner |
| 05/06/2008 | CA2280727C Bicyclic amino acids |
| 05/02/2008 | WO2008052075A2 Benzoxazine derivatives and uses thereof |
| 05/02/2008 | WO2008049808A1 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 05/02/2008 | WO2008029168A3 Treatment of duchenne muscular dystrophy |
| 05/02/2008 | CA2664143A1 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 05/01/2008 | US20080103302 Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal or cancer |
| 05/01/2008 | US20080102405 Nitrogen-containing organic compound, resist composition and patterning process |
| 05/01/2008 | US20080100207 cyclopentaphenanthrene-based compound which is adapted for both dry and wet processes, and has excellent thermal stability and good charge transport and emission characteristics |
| 04/30/2008 | EP1916527A1 Analysis of mass spectral data in the quiet zones |
| 04/30/2008 | EP1915339A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 04/30/2008 | CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 04/29/2008 | US7365222 Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials |
| 04/29/2008 | US7365197 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 04/29/2008 | US7365069 Pyrimidone derivatives |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/29/2008 | US7365063 5-HT6 receptor and/or 5-HT2A receptor modulators; CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, sleep disorders, feeding disorders |
| 04/24/2008 | WO2008048914A1 Polycyclic compounds which modulate the cb2 receptor |
| 04/24/2008 | WO2008047769A1 Glucose metabolism ameliorating agent |
| 04/24/2008 | WO2007085729A3 Novel method for synthesis of 1,4-morpholine-2,5-diones |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/24/2008 | US20080096848 Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of Apoptosis |
| 04/24/2008 | US20080093987 Organoelectroluminescent compound and organoelectroluminescent device employing the same |
| 04/23/2008 | EP1912957A1 Ep4 receptor agonist, compositions and methods thereof |
| 04/23/2008 | EP1689493A4 Calcitonin gene related peptide receptor antagonists |
| 04/23/2008 | CN100382847C Ligand compound for image diagnosis and its preparing method and compound for image diagnosis and its intermediate preparation |
| 04/22/2008 | US7361757 an N-protected morpholinone is reactedeither with allyl bromide or allyl triflate; hydrogenation; subjected to the action of LiOH, then esterification; chemical intermediates |
| 04/22/2008 | US7361756 by mixing 7-hydroxy-tetrahydroquinolinone, dibromobutane, and at least one base to form a reaction mixture; using phase transfer catalysts; or using a low boiling point solvent |
| 04/22/2008 | US7361755 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines |
| 04/22/2008 | US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/22/2008 | US7361655 Pharmaceutically effective compounds |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/17/2008 | US20080090785 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/16/2008 | EP1911749A1 New long-working Beta-2 agonists and their use as medicine |
| 04/16/2008 | EP1910320A2 Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
| 04/16/2008 | EP1910319A1 Use of tetrahydrobenzoxazines as stabilisers |
| 04/16/2008 | EP1910273A2 10-substituted tetracyclines and methods of use thereof |
| 04/16/2008 | EP1414787B1 New derivatives of substituted anilines with herbicidal activity |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358248 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatases |
| 04/10/2008 | WO2006018853A3 Novel polymorphs of efavirenz |
| 04/10/2008 | US20080085895 Substituted Chiral Fused [1,2]Imidazo[4,5-C] Ring Compounds |
| 04/09/2008 | EP1907372A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 04/09/2008 | EP1907369A1 Thiazoles derivatives as ampk activator |
| 04/09/2008 | CN101157619A Process for producing intermediate for benzoxazine derivative |
| 04/09/2008 | CN100379743C New oxabispidine compound useful in treatment of cardiac arrhythmias |
| 04/08/2008 | US7354920 Aryl and heteroaryl morpholine derivatives |
| 04/08/2008 | US7354915 as agonist; treatment of uterine fibroids, endometriosis, dysmenorrhea; anticarcinogenic: breast, uterine, ovarian, prostate cancers and meningioma; hormone replacement therapy; menopausal and post-menopausal hormone replacement therapy; skin disorders |
| 04/08/2008 | CA2382593C Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use |
| 04/03/2008 | WO2007109288A3 Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use |
| 04/03/2008 | US20080079356 Organoelectroluminescent compound and organoelectroluminescent device employing the same |
| 04/02/2008 | CN100378083C Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351821 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/01/2008 | US7351705 Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient |
| 03/27/2008 | WO2008036843A2 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
| 03/27/2008 | US20080076770 -[4-(4,5-dichloro-1H-imidazol-1-yl)-phenyl]-3-(4-trifluoromethyl-phenyl)-urea; useful for treating hypertensive, cardiovascular, inflammatory, and diabetes related diseases |
| 03/27/2008 | US20080076766 Piperidine Derivatives As Renin Inhibitor |
| 03/27/2008 | US20080076765 4aRS,11bRS)-4-propyl-3,4,4a,5,6,8,9,11b-octahydroisoindolo[5,6-h][1,4]benzoxazin-10(2H)-one or salts useful in the treatment of disorders of CNS that involve the dopaminergic system: Parkinson's disease, hyperprolactinaemia, sexual dysfunction, depression, anxiety, Alzheimer's/neurodegenerative disease |
| 03/27/2008 | CA2664411A1 Platelet adp receptor inhibitors |
| 03/26/2008 | EP1902049A2 Non-steroidal progesterone receptor modulators |
| 03/26/2008 | CN101151255A 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 03/26/2008 | CN100376565C Method for preparing fused oxazinones |
| 03/26/2008 | CN100376560C New tricyclic compounds and their use as medicine, process for their preparation and pharmaceutical compositions containing them |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348339 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348322 6-{2-Hydroxyimino-3-[1-(2-trifluoromethyl-phenyl)-cyclobutyl]-propylamino}-4-methyl-benzo[d][1,2]oxazin-1-one; antiallergic, asthma, artritis, graft versus host disease; side effect reduction; GR/ligand complex represses transcription of pro-inflammatory genes by directly interacting with NF-kB or AP-1 |
| 03/25/2008 | CA2359987C 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 03/20/2008 | WO2008031811A1 Nitrate esters of aminoalcohols |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070909 Of amine salts of 1-(3-(2-(3-methanesulfonamino-4-hydroxyphenyl)-2-hydroxyethylamino)-3,3-dimethylpropyl)-1,2-dihydro-4H-3,1-benzoxazin-2-one betamimetics; physicochemical properties for use in inhalable form; treating respiratory system disorders |
| 03/20/2008 | US20080069851 Substituted n-aminomethylene sulfonamides, production and use thereof as medicaments |
| 03/20/2008 | CA2663129A1 Nitrate esters of aminoalcohols |
| 03/19/2008 | CN101143855A Method for synthesizing esters of n-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril |
| 03/18/2008 | US7345091 Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/13/2008 | WO2008029168A2 Treatment of duchenne muscular dystrophy |
| 03/13/2008 | WO2006099385A8 Stabilized compositions of volatile alkylating agents and methods of using thereof |
| 03/13/2008 | US20080064873 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents |
| 03/13/2008 | US20080064871 Production Method of Nitrogen-Containing Fused Ring Compounds |
| 03/13/2008 | US20080064694 Multi-Phase Release Methscopolamine Compositions |
| 03/13/2008 | US20080064693 N-2 Adamantanyl-2-Phenoxy-Acetamide Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/12/2008 | EP1708713B1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 03/06/2008 | WO2008026046A1 Morpholine d3 dopamine antagonists |
| 03/06/2008 | WO2007125398A3 : sulfonamide compounds as antagonists of the n-type calcium channel |
| 03/06/2008 | US20080058516 Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing alpha-keto amide compound using them |
| 03/06/2008 | US20080058514 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
| 03/06/2008 | US20080058302 Sulfamoyl Benzamides and Methods of Their Use |
| 03/06/2008 | US20080057347 Overcoatings; receivers; thermal printing; for security documents |